Topics

Opinion: Pharmaceutical mergers and megamergers stifle innovation

04:40 EDT 10 Jul 2019 | STAT

Presidential candidates, lawmakers, policymakers, and the public should put pressure on regulators like the FTC to apply more scrutiny to multibillion-dollar mergers in the pharma industry.

Original Article: Opinion: Pharmaceutical mergers and megamergers stifle innovation

NEXT ARTICLE

More From BioPortfolio on "Opinion: Pharmaceutical mergers and megamergers stifle innovation"

Quick Search

Relevant Topic

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.